Arquivamento definitivo - Art. 33 da LPI
#11.1.1
04/08/2025
RPI 2831
Application data
Number
112023013041Type
Filing
Publication
PCT
US2022070112 The application was abandoned: examination was not requested within the 36 months following the 01/10/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 04/08/2025. We update with every new RPI gazette, published weekly.
Applicants
BAYER HEALTHCARE LLC
US
Inventors
A. E. (pessoa física)
US
B. M. (pessoa física)
ES
M. P. (pessoa física)
ES
M. S. (pessoa física)
ES
IPC Classification
Priority claims
US
63/135,885 · 01/11/2021
Abstract
FORMULAÇÕES DE GEL LÍQUIDO CONCENTRADO CONTENDO SAIS DE NAPROXENO. A presente invenção se refere a cápsulas de minigel macio, particularmente cápsulas gelatinosas macias contendo sal de naxopreno como um ingrediente ativo. Se refere, em geral, a cápsulas gelatinosas macias, que contêm formulações de alta concentração de sódio de naproxeno.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
04/08/2025
RPI 2831
#11.1
01/21/2025
RPI 2820
#1.3
08/01/2023
RPI 2743
#1.1
07/11/2023
RPI 2740
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.